- Home
- UFCS vs QDEL Comparison
UFCS vs QDEL Comparison
Compare UFCS & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UFCS | QDEL |
|---|---|---|
| Founded | 1946 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 936.4M | 1.0B |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | UFCS | QDEL |
|---|---|---|
| Price | $47.95 | $11.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $40.50 | $28.25 |
| AVG Volume (30 Days) | 103.6K | ★ 2.3M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | ★ 87.45 | 45.35 |
| EPS | ★ 1.15 | N/A |
| Revenue | $1,386,412,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $11.80 | $3.51 |
| Revenue Next Year | $8.77 | $3.86 |
| P/E Ratio | $42.08 | ★ N/A |
| Revenue Growth | ★ 10.62 | N/A |
| 52 Week Low | $25.81 | $9.92 |
| 52 Week High | $49.94 | $35.58 |
Technical Indicators
Market Signals| Indicator | UFCS | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 69.06 | 47.14 |
| Support Level | $34.84 | $10.39 |
| Resistance Level | N/A | $12.85 |
| Average True Range (ATR) | 1.59 | 0.92 |
| MACD | 0.28 | 0.27 |
| Stochastic Oscillator | 82.70 | 66.21 |
Price Performance
Historical ComparisonAbout UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.